Catalyst
Slingshot members are tracking this event:
Kite Expects Phase 2 Data in 2017 for Expansion Study Evaluating KTE-C19 in Aggressive Non-Hodgkin Lymphoma
- Source Link:
- http://ir.kitepharma.com/events.cfm
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KITE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 08, 2017
Occurred Source:
https://www.hematologyandoncology.net/archives/february-2017/an-interim-analysis-of-the-zuma-1-study-of-kte-c19-in-refractory-aggressive-non-hodgkin-lymphoma/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2, Expansion Study, Kte-c19, Aggressive Non-hodgkin Lymphoma
